I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 38% ± 18% | |
| GABAergic neuron | 5 studies | 42% ± 14% | |
| interneuron | 3 studies | 36% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 38% ± 18% | |
| GABAergic neuron | 5 studies | 42% ± 14% | |
| interneuron | 3 studies | 36% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 39% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 89% | 1521.56 | 160 / 180 | 55% | 1.87 | 238 / 430 |
| brain | 90% | 6529.51 | 2391 / 2642 | 50% | 2.15 | 351 / 705 |
| spleen | 98% | 5234.29 | 237 / 241 | 0% | 0 | 0 / 0 |
| muscle | 97% | 1919.98 | 781 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 10.57 | 2 / 258 | 37% | 3.20 | 85 / 230 |
| heart | 14% | 68.63 | 117 / 861 | 0% | 0 | 0 / 0 |
| stomach | 4% | 21.53 | 15 / 359 | 5% | 0.13 | 14 / 286 |
| uterus | 3% | 15.97 | 5 / 170 | 5% | 0.15 | 23 / 459 |
| intestine | 2% | 10.29 | 18 / 966 | 5% | 0.11 | 27 / 527 |
| lung | 2% | 9.73 | 13 / 578 | 5% | 0.14 | 54 / 1155 |
| breast | 3% | 13.33 | 13 / 459 | 2% | 0.04 | 20 / 1118 |
| esophagus | 1% | 3.73 | 13 / 1445 | 3% | 0.08 | 6 / 183 |
| adipose | 4% | 18.36 | 43 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 2% | 9.11 | 5 / 245 | 0% | 0.01 | 2 / 502 |
| blood vessel | 2% | 10.18 | 30 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| bladder | 0% | 0 | 0 / 21 | 2% | 0.09 | 11 / 504 |
| pancreas | 0% | 0 | 0 / 328 | 2% | 0.05 | 3 / 178 |
| skin | 1% | 4.32 | 12 / 1809 | 1% | 0.01 | 3 / 472 |
| thymus | 1% | 2.60 | 4 / 653 | 0% | 0.05 | 3 / 605 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 5 / 901 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
| peripheral blood | 0% | 0.86 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005228 | Molecular function | intracellular sodium-activated potassium channel activity |
| GO_0015271 | Molecular function | outward rectifier potassium channel activity |
| Gene name | KCNT1 |
| Protein name | Potassium sodium-activated channel subfamily T member 1 KCNT1 protein Potassium channel subfamily T member 1 (KCa4.1) |
| Synonyms | KIAA1422 |
| Description | FUNCTION: Outwardly rectifying potassium channel subunit that may coassemble with other Slo-type channel subunits. Activated by high intracellular sodium or chloride levels. Activated upon stimulation of G-protein coupled receptors, such as CHRM1 and GRIA1. May be regulated by calcium in the absence of sodium ions (in vitro) (By similarity). . |
| Accessions | A0A0D9SEY3 ENST00000628528.2 [Q5JUK3-4] C9J9Y7 C9JAX7 ENST00000460750.5 A0A6Q8PGM3 ENST00000631073.2 C9JYL2 Q5JUK3 A0A0D9SFC8 ENST00000491806.6 A0A0R4J2E0 ENST00000631193.1 ENST00000487664.5 [Q5JUK3-2] ENST00000674572.1 ENST00000676421.1 ENST00000486577.6 ENST00000473941.5 ENST00000630792.2 A0A0K2GMW5 ENST00000488444.6 [Q5JUK3-1] ENST00000263604.5 F8WC49 A0A6Q8PFI9 ENST00000371757.7 [Q5JUK3-3] ENST00000490355.6 A0A6Q8PFE8 ENST00000675090.1 ENST00000675399.1 C9JBV2 A0A0D9SFR1 A0A6Q8PFS3 |
